Who has invested in Kivu Bioscience?

Novo Holdings are named among the investors backing Kivu Bioscience.

Kivu Bioscience Funding: $92M Raised, Series A (2024)

Kivu Bioscience funding overview

Kivu Bioscience has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for Kivu Bioscience runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings.

Kivu Bioscience at a glance

Total raised: $92M
Latest round: Series A
Latest round date: October 2024
Notable investors: Novo Holdings

Frequently asked about Kivu Bioscience funding

How much has Kivu Bioscience raised?: Kivu Bioscience has raised $92M in total disclosed funding across the rounds on record.
Who has invested in Kivu Bioscience?: Novo Holdings are named among the investors backing Kivu Bioscience.
What was the latest Kivu Bioscience funding round?: The most recent disclosed round is a Series A, announced in October 2024.
Where is Kivu Bioscience based?: No headquarters location is disclosed for Kivu Bioscience.
When did Kivu Bioscience last raise?: The last disclosed Kivu Bioscience round closed in October 2024 at Series A.

We update the Kivu Bioscience record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.

Kivu Bioscience Funding: $92M Raised, Series A (2024)

Kivu Bioscience funding overview

Kivu Bioscience at a glance

Frequently asked about Kivu Bioscience funding

Companies related to Kivu Bioscience (18)

Browse related funding lists (4)